Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kalvista Pharmaceuticals Inc

13.79
+0.02000.15%
Volume:55.95K
Turnover:770.52K
Market Cap:685.58M
PE:-3.71
High:13.91
Open:13.89
Low:13.53
Close:13.77
Loading ...
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024

Major Issues Report

Form 8-K - Current report
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 29, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 08, 2023

Major Issues Report

Form 8-K - Current report
Dec 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 29, 2023

Major Issues Report

Form 8-K - Current report
Sep 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 08, 2023

Major Issues Report

Form 8-K - Current report
Sep 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 10, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 10, 2023

Major Issues Report

Form 8-K - Current report
Jun 20, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
Mar 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]